Extension Study to Evaluate the Safety and Tolerability of Tezepelumab in Adults and Adolescents With Severe, Uncontrolled Asthma
Clinical trial NCT03706079 · COMPLETED
Trial details
- NCT number
- NCT03706079
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-07
- Primary completion
- 2021-10-26
- Enrollment
- 951
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.